These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8879803)

  • 1. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
    Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
    Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
    Braegger CP; Albisetti M; Nadal D
    J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):104-6. PubMed ID: 8576800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis.
    Chocarro Martínez A; Gonzalez A; Garcia I
    Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
    Ruhnke M; Adler A; Müller FM
    Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
    [No Abstract]   [Full Text] [Related]  

  • 7. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
    Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
    AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.
    Ng TT; Denning DW
    J Infect; 1993 Mar; 26(2):117-25. PubMed ID: 8473758
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B.
    Turner DL; Johnson SA; Rule SA
    J Infect; 1999 Jan; 38(1):51-3. PubMed ID: 10090510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    Ustianowski AP; Leake H; Evans S
    Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida infection in HIV positive patients 1985-2007.
    Traeder C; Kowoll S; Arastéh K
    Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
    Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H
    Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
    Barbaro G; Barbarini G; Calderon W; Grisorio B; Alcini P; Di Lorenzo G
    Gastroenterology; 1996 Nov; 111(5):1169-77. PubMed ID: 8898629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.